Centre for Probe Development and Commercialization
3 clinical trials · Sponsor
◉ Watch Centre for Probe Development and Commercialization
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer. (NCT04644822) | Centre for Probe Development and Commercialization | 2020-12-21 |
| A Safety and Biodistribution Study of [I-124]-CPD-1028 Injection in Solid Tumours (NCT02134340) | Centre for Probe Development and Commercialization | 2014-06-01 |
| A Single Centre Open Label Comparison of [I-123]-Ortho-Iodohippuric Acid (OIH) With [Tc-99m]-Mercaptoacetyltriglycine (MAG3) for Assessment of Renal Tubular Function (NCT01496391) | Centre for Probe Development and Commercialization | 2012-09-01 |
Track Centre for Probe Development and Commercialization automatically
Every clearance here is in the API, with alerts when new ones post.